57
Participants
Start Date
November 30, 2002
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
Simvastatin
Subjects randomized to this arm will be pretreated with 80 mg (2 pills) simvastatin approximately one hour prior to percutaneous coronary intervention.
Placebo
Subjects randomized to this arm will be pretreated with 2 placebo pills approximately one hour prior to percutaneous coronary intervention.
Mayo Clinic, Rochester
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
Mayo Clinic
OTHER